Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
Revenue projections:
Revenue projections for ANURAS ANURAS's projected revenue decline from last year is likely to make investors cautious. Lower revenues often hurt a company's bottom line, leading investors to be concerned about the company's ability to maintain profitability and deliver strong financial results in the future.
Financial Ratios:
currentRatio
0.000000
forwardPE
50.302223
debtToEquity
44.566000
earningsGrowth
7.611000
revenueGrowth
0.911000
grossMargins
0.552830
operatingMargins
0.192670
trailingEps
11.270000
forwardEps
21.980000
ANURAS's elevated forward PE points to potential overvaluation, limiting further price gains and increasing the likelihood of a correction. This valuation metric must be assessed in conjunction with other fundamentals for a balanced investment outlook. With positive growth in both earnings and revenue, Anupam Rasayan India Ltd is expected to grow its business. These indicators highlight a strong financial outlook, with the company on track for continued expansion and increasing profitability. ANURAS's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that ANURAS is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.
Price projections:
Price projections for ANURAS ANURAS's price projections have been revised upward over time, suggesting that analysts are becoming more confident in the company's future. This trend points to increased optimism about ANURAS's ability to grow.
Recommendation changes over time:
Recommendations trend for ANURAS
Analysts' recent buy bias toward ANURAS suggests the stock is gaining favor as a strong investment choice. This optimism could drive more investors to see ANURAS as a smart place to invest, further bolstering confidence in the company's long-term growth and potential returns.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An in-depth look at the UK’s Q2 2025 GDP release by ONS,...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.